CFO Capital Management’s Amgen AMGN Stock Holding History

CFO Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$271K	Hold	770	–	–	0.22%	92
2025 Q4	$252K	Buy	+770	New	+$244K	0.19%	96

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

CFO Capital Management's AMGN Position: Q1 2026 in Review

CFO Capital Management held its Amgen (AMGN) position steady in Q1 2026 at 770 shares worth $271K. The position accounts for 0.22% of the portfolio, ranked #92.

CFO Capital Management first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

CFO Capital Management held 770 shares of Amgen worth $271K as of Q1 2026.
CFO Capital Management left its Amgen share count unchanged in Q1 2026.
Amgen made up 0.22% of CFO Capital Management's portfolio in Q1 2026, its #92 holding.
CFO Capital Management first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
3,139 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on CFO Capital Management's 13F filing for Q1 2026, filed 4 May 2026.